Tune Therapeutics
epigenetic editing, genetic tuning, TEMPO
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
epigenetic editing, genetic tuning, TEMPO
0-100 chain-logic scale · 15 dimensions · scored on public evidence
This study will be conducted to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of Tune-401 in adult participants with Chronic Hepatitis B.
Facebook Explore the things you love . Log into Facebook Email or mobile number Password Log in Forgot password? Create new account English (US) فارسی العربية Türkçe Deutsch Français (France) Polski More languages… Sign Up Log In Messenger Facebook Lite Video Meta Pay Meta Store Meta Quest Ray-Ban Meta Meta AI Instagram Threads Privacy Policy Privacy Center About Create ad Create Page Developers Careers Cookies Ad choices Terms Help Contact Uploading & Non-Users Meta © 2026
The Tune Supply Shop Skip to content Email [email protected] Home Duramax Duramax L5P (2024-2026) L5P (2024-2026) 2024-2025 L5P Tuning Bundles 2024-2025 L5P Hard Parts L5P (2020-2023) L5P (2020-2023) 2020-2023 L5P Tuning Bundles 2020-2023 L5P Hard Parts 2020-2023 L5P Turbos L5P Platform All 2020-2023 L5P Products L5P (2017-2019) L5P (2017-2019) 2017-2019 L5P Tuning Bundles 2017-2019 L5P Hard Parts 2017-2019 L5P Turbos L5P Platform All 2017-2019 L5P Products LML (2011-2016) LML (2011-2016) LML Tuning Bundles LML Hard Parts LML Turbos LML Platform All LML Products LMM (2007.5-2010) LMM (20
Fine-tune your focus and unleash your collaboration | Haworth Europe */ --> Skip to Main Content Skip To Search Skip To Footer DISCOVER HAWORTH SHOP NOW WHERE TO BUY WORK WITH US MYHAWORTH Europe | English North America | English Europe | English (currently selected) Europe | Deutsch Europe | Français Europe | Español Asia Pacific | English Asia Pacific | 中文 Asia Pacific | 日本語 Latin America | English Products Chairs Office chairs Conference chairs Visitor chairs Stools Auditorium Lounge Sofas & Armchairs Soft seating Poufs & Ottoman Desks & Tables Office desks Conference tables Mee
Leading with Awareness: Why Ho... - Mark Langley Horsemanship Solutions for Partnership - Apple Podcasts Buscar Inicio Novedades Lo más escuchado Buscar 13 de junio 25 min Leading with Awareness: Why Horses Tune Out and How to Keep Them Thinking Mark Langley Horsemanship Solutions for Partnership Reproducir Why do some horses become "stuck in the mud" when leading, while others seem to switch off and stop responding altogether? In this episode, Mark explores some of the most common leading challenges horse owners face and explains why the answer often lies in awareness rather than pressure. He … elp horses that hate halters. If you’d like to better understand your horse and apply these concepts step-by-step, join the Mark Langley Online Membership today. Sitio web del episodio Información Programa Mark Langley Horsemanship Solutions for Partnership Frecuencia Cada semana Publicado 13 de junio de 2026 a las 11:16 p.m. UTC Duración 25 min Temporada 2 k Episodio 323 Clasificación Apto Estados Unidos (Español México) العربية Русский 简体中文 Français (France) 한국어 Português (
Error Page - Film Independent Login Home Donate Home Spirit Awards Presents Programs Events Blog Sorry something unexpected occured Please retry your request again Error Details: ID: 9534152 Code: Description: HOME SPIRIT AWARDS PRESENTS PROGRAMS EVENTS BLOG Film Independent | 5670 Wilshire Blvd., 9th Floor | Los Angeles, CA 90036 | T: 323 556 9300 | F: 323 556 9303 © 2011-2024 Film Independent. All rights reserved. Privacy Policy .
The Scientist - Time to tune in! A collaboration between... Facebook Log In The Scientist's Post The Scientist Verified account May 8 · Shared with Public Time to tune in! A collaboration between a physician and composers sees genomes become music in an effort to bring awareness to rare diseases, one composition at a time. Read the full article in May's TS Digest via the link in the comments. All reactions: 35 3 comments 12 shares Like Comment Most relevant Author The Scientist Learn more: https://bit.ly/4n3jrqH THE-SCIENTIST.COM Genome Music: Rare Disease Sequences Turn Into Songs |
2026 Sponsorship – Krooztune Skip to content Home Home Shop By Suspension Shop By Suspension WP Suspension WP Suspension WP Xact 48 USD fork WP Xplor PDS Shock WP AER48 Fork WP Xplor 48 Fork Enduro / Offroad Enduro / Offroad KTM KTM EXC / -F / XC-W 23-25 EXC /-F / XC-W 17-23 XC / XC-F 23-25 XC / XC-F 17-22 Husqvarna Husqvarna FE / TE 24-25 FE / TE 19-23 FX / TX 23-25 FX / TX 17-22 Gas Gas Gas Gas Gas Gas All Beta Beta Beta RR X-Pro 2025 Yamaha Yamaha WR 250/450 WP Fork Kit and parts WP Fork Kit and parts XACT Fork Kit and Parts XPLOR Fork Kit and Parts WP Shock Kit and parts WP Shock Kit … s updated on your season progress Simple. Real. Genuine partnership. Who Should Apply? Juniors and families who live at the track Riders progressing through club, state, and national racing Hard workers who want to level up Loyal Krooztune customers Positive role models on social media If you want to be part of a brand that backs the kids, supports families, and cares about the sport , we’d love to hear from you. Apply Now Submit your 2026 Rider Application below and tell us
Tune Insight: Meet the Venture Leader Technology orchestrating secure data collaboration About Venture Leaders Programs & Destinations 20 Years Success Stories News --> About Venture Leaders Programs & Destinations 20 Years Success Stories News Upcoming Name: Juan Ramon Troncoso-Pastoriza Location: Lausanne, Switzerland Nationality: Spanish Education: PhD from the University of Vigo, 2012 Job title: CEO and co-founder Number of employees: 9 Money raised: ~CHF 1 million First touchpoint with Venturelab: Venture Kick , 2021-2022 Whom does your product or solution help, an … & Co. Related stories Tune Insight secures EUR 1.8 million Eurostars grant for revolutionary pediatric cybersecurity project Swiss cybersecurity startup Tune Insight has emerged victorious in the highly competitive Eurostars program, clinching a EUR 1.8 million grant. The awarded fund... Read more Transforming the data landscape: Tune Insight raises USD 3.4 Million to pioneer the secure insight economy Tune Insight's visionary approach ensures that raw, sensitive d
Instagram Instagram Meld aan Teken in Maak toe Mis nooit ’n plasing deur mdwwien nie Teken in op Instagram om op die hoogte te bly. Teken in Meld aan mdwwien en 5 ander Nog opsies mdwwien 10 w. The @in.tune.alliance has launched a new call for teacher collaboration projects — an exciting chance to co-create innovative educational initiatives with colleagues across Europe. 🚀 This call supports projects that aim to: • Develop new approaches to learning and teaching • Foster international collaboration between institutions • Experiment with innovative and interdisciplinary formats • Strengthen t … rk 😎 Don’t miss this opportunity to turn your ideas into impactful projects! ❗️Deadline for applications: 4 May 2026 👉 More info - Link in Bio! Laai meer opmerkings Nog geen opmerkings nie Begin die gesprek. Hou van 50 Maak opmerking Deel Stoor 16 April Meld aan om van te hou of kommentaar te lewer. Meer plasings deur mdwwien Draaiband Draaiband Draaiband Snit Draaiband Snit Draaiband Snit Snit Sien meer plasings Meta Meer oor Blog Poste Hulp API Privaatheid Bepalings Liggi
Instagram Instagram Log In Sign Up Close Never miss a post from sse_asunm Sign up for Instagram to stay in the loop. Sign up Log in sse_asunm Verified • Follow More options sse_asunm Verified 29w Now introducing our Sponsorship Coordinator… Stay tune this week for more staff intros! Load more comments joewebbb Like Reply andri_ulibarri 29w 🙌🙌🙌 Like Reply angle_serrano_ 29w Yes Carson!! Like Reply jromero_ll 29w 🔥🔥🔥 Like Reply karisdaskalos 29w Yup 💸 Like Reply _andrewnorton 29w 👑 Like Reply Like 60 Comment 6 Share Save December 4, 2025 Log in to like or comment. More posts from sse_asu
Tune Protect Group partnership | Collinson Group Pular para o conteúdo principal Mais recente : Priority Pass launches first dedicated Fast Track lane in Central Asia at Tashkent International Airport Fale conosco Portuguese O Grupo Nossas empresas Nosso impacto Insights Carreiras Sala de imprensa Search O Grupo Sobre nós Nosso propósito Nossa liderança Nossa presença global Nossas empresas Empresas do Collinson Group Collinson International Airport Dimensions Value Dynamx Collinson Insurance Collinson Investments Nosso impacto Impacto no Collinson Group A Collinson Foundation Início / Newsroo
Genome Enhancer Network Exploration – Tuning expression through enhancer collaboration (GENE-TUNE) - University of Vienna Skip to main navigation Skip to search Skip to main content University of Vienna Home u:cris Info Link opens in a new tab Deutsch English Search content at University of Vienna Home Persons Units and bodies Projects Publications Activities Prizes Press/Media Genome Enhancer Network Exploration – Tuning expression through enhancer collaboration (GENE-TUNE) Bücker, Christa (Project Lead) Martins, Angela (Admin) Max Perutz Labs - 746 Project : Research funding Overview … similar technologies. For all open access content, the relevant licensing terms apply We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies Log in to u:cris Link opens in a new tab University of Vienna data protection policy Link opens in a new tab Impressum Link opens in a new tab About web accessibility Link opens in a new tab Report vulnerability Link opens in a new tab Co
New Partnership with PTBio - a-tune software AG de en Back Homepage Products & Services Company News & Events Downloads Contact Request Demo Support Resource Library Legal Notice Privacy Statement tick@lab Animal Research Facility Software tick@lab Research Compliance Software Data Integration & Enterprise Applications Archive.Manager E-WorkBook.Deployment Data.Manager File.Manager Catalog.Inspector Chemistry.System.Integration Label.Printer In-vivo.Workbench Application.Insight Template.Reporter Study.Reporter Information.Portal tick@lab add-ons About us Careers Latest announce … required service and unblock content You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers. More Information Unblock content Accept required service and unblock content You are currently viewing a placeholder content from Turnstile . To access the actual content, click the button below. Please note that doing so will share data with third-party providers. More Information Unblock content Accept require
2026 Sponsorship – Krooztune Skip to content Home Home Shop By Suspension Shop By Suspension WP Suspension WP Suspension WP Xact 48 USD fork WP Xplor PDS Shock WP AER48 Fork WP Xplor 48 Fork Enduro / Offroad Enduro / Offroad KTM KTM EXC / -F / XC-W 23-25 EXC /-F / XC-W 17-23 XC / XC-F 23-25 XC / XC-F 17-22 Husqvarna Husqvarna FE / TE 24-25 FE / TE 19-23 FX / TX 23-25 FX / TX 17-22 Gas Gas Gas Gas Gas Gas All Beta Beta Beta RR X-Pro 2025 Yamaha Yamaha WR 250/450 WP Fork Kit and parts WP Fork Kit and parts XACT Fork Kit and Parts XPLOR Fork Kit and Parts WP Shock Kit and parts WP Shock Kit … s updated on your season progress Simple. Real. Genuine partnership. Who Should Apply? Juniors and families who live at the track Riders progressing through club, state, and national racing Hard workers who want to level up Loyal Krooztune customers Positive role models on social media If you want to be part of a brand that backs the kids, supports families, and cares about the sport , we’d love to hear from you. Apply Now Submit your 2026 Rider Application below and tell us
Charity Golf Tournament Technology Sponsorship | GolfStatus Cart 0 Fundraising Enhancers How It Works Resource Library Golf for Good Blog Log In Get Started Back GolfStatus Rewards Technology Sponsorship Pin Flags Hole-In-One Contests Hole Signage Back Solutions Golf Tournament Website App Golf Facilities Marketplace Support Pricing FAQs Back Resource Library Webinars Case Studies Cart 0 Fundraising Enhancers GolfStatus Rewards Technology Sponsorship Pin Flags Hole-In-One Contests Hole Signage How It Works Solutions Golf Tournament Website App Golf Facilities Marketplace Support Pricing FAQs R
John McHutchison - CEO & Chairman, Tune Therapeutics | YesPress John McHutchison named CEO & Chairman of Tune Therapeutics - March 2025 Tune Therapeutics closes $175M Series B - January 2025 TEMPO platform targets epigenome editing for chronic disease McHutchison helped cure hepatitis C for 3.2 million+ patients at Gilead Officer of the Order of Australia (AO) - 2018 300+ peer-reviewed publications across a 30-year career Total funding raised: $397M at Tune Therapeutics Tune-401: Lead epigenetic silencing program targeting chronic hepatitis B John McHutchison named CEO & Chairman of Tu … nd trained at the University of Melbourne, earning his MBBS before completing a residency in internal medicine and a fellowship in gastroenterology at the Royal Melbourne Hospital. He then crossed the Pacific for a post-doctoral fellowship in liver diseases at the University of Southern California - the kind of move that signals ambition measured in decades, not quarters. The liver became his territory. He spent nearly ten years at Scripps Clinic and Research Foundation in La … ighest civilian honors. Education ● MBBS, University of Melbourne ● Fellowship in Gastroenterology, Royal Melbourne Hospital ● Post-doc Fellowship in Liver Diseases, USC ● Member, Royal Australasian College of Physicians Current Roles ● CEO & Chairman, Tune Therapeutics ● Director & S&T Committee Chair, Assembly Biosciences ● Chairman, Comanche Biopharma Australia ● Adjunct Professor, Duke University Medicine Career … niversity of Melbourne & Royal Melbourne Hospital - MBBS, internal medicine residency, and gastroenterology fellowship. Post-doctoral fellowship in liver diseases at USC; assistant professorship. 1990s - 2000s Scripps Clinic and Research Foundation, La Jolla, CA - Nearly a decade as Medical Director of Liver Transplantation and Director of GI/Hepatology. Where the clinical urgency became research ambition. 2000s - 2010 Duke University Medical Center - Associate Director, … ne of Australia's highest civilian honors. 🏅 Advance 2020 Global Impact Award Recognized for global impact in science, medicine, and the advancement of Australians on the world stage during his tenure at Assembly Biosciences. 📚 300+ Peer-Reviewed Publications A scientific bibliography spanning hepatology, antiviral medicine, clini
2021 CIP CUP Spring Tune Up - Bay Sponsorship — GIPA Georgia Intellectual Property Alliance® Sign In My Account HOME ABOUT PROGRAMS CAREERS & JOBS RESOURCES FOUNDERS & SPONSORS CALENDAR Back About GIPA GIPA Board Volunteer Contact Back IP Roundtables Corporate Entertainment, Arts, & Sports Inventors Law Firm Leadership Council Patent Agents Startups Venture Capital Recognition IP Community Service Awards IP Legends Awards IP Startups Awards CIP CUP Charity G … rs Make a Donation Back IP Events Calendar IP Events by Month IP Events Archive Submit an IP Event Sign In My Account HOME ABOUT About GIPA GIPA Board Volunteer Contact PROGRAMS IP Roundtables Corporate Entertainment, Arts, & Sports Inventors Law Firm Leadership Council Patent Agents Startups Venture Capital Recognition IP Community Service Awards IP Legends Awards &nbs … ake a Donation CALENDAR IP Events Calendar IP Events by Month IP Events Archive Submit an IP Event Prosper Under Our Umbrella® GIPA Progams 2021 CIP CUP Spring Tune Up - Bay Sponsorship Previous 2021 Corporate IP Institute Next Corporate IP Roundtable Keynote 2021 CIP CUP Spring Tune Up - Bay Sponsorship 2021 CIP CUP Spring Tune Up - Bay Sponsorship $500.00 Not Available Sponsor a Top Golf Bay! Facebook 0 Twitter LinkedIn 0 Reddit Pinterest 0 Prosper under our umbrella ® Geor
E*TRADE is proud to partner with a co-presenting sponsorship around CBS’ long-running hit reality show, Survivor. Tune in to the milestone 50th season on Wednesday, February 25, 2026, on CBS at 8:00 p.m. ET and look for our spot. | E*TRADE from Morgan Stanley
Driving intent: The impact of NPR sponsorship on movie & TV tune-in | National Public Media Skip to Content Audience Platforms Back Audio Connect with listeners as they tune in to NPR across platforms throughout the day. Radio Podcasts Voice Display Be seen in a brand safe, uncluttered environment with the NPR website and apps. Video Align with public media stories worth watching on TV and online. PBS Events Connect in-person or virtually with sponsorship of NPR events. Products NPM Creative Insights Contact Us Contact Us Toggle Menu Insights Driving intent: The impact of NPR sponsorship o
Academy Sponsorship Meta NEWS LATEST NEWS VIDEOS Club ROSTER Community Technical Staff PARTNERS SCHEDULE MATCH SCHEDULE Promo Schedule How to TUNE IN BIKE BUS Contests & Promotions SHOP Portland Thorns CLOSE Tickets Single Match Tickets Memberships Groups Hospitality Premium Seating Account Manager Schedule 2026 Regular Season How to Watch Promotional Schedule Pub Partners Contests & Promotions Shop Jerseys Womens Mens Youth Accessories News Latest News Videos Newsletter COMMUNITY Thorns for All Toyota Tickets for Tables Lauren Holiday Impact Award Regional Training Center West Club Ro … ideos Newsletter Community Thorns For All EmpowHER Awards Lauren Holiday Impact Award Regional Training Center (West) Club Roster Technical Staff Standings Stats Academy About Staff Sponsorship Events & Tryouts PARTNERS Partnerships Kaiser Permanente Performance Center HQ Hyatt Where to Stay Ring Alaska Airlines Fred Meyer Boost Rewards About Contact Us Media Resources Business Operations Staff Providence Park NWSL About News Standings Stats Schedule TICKETS MENU Secure y … Providence Park Community Thorns For All EmpowHER Awards Lauren Holiday Impact Award Tickets to Tables Regional Training Center (West) NWSL About News Standings Stats Schedule © Portland Thorns. All Rights Reserved.
Sponsorship Information | UHGiving Skip to main content Close Find Doctors Services Locations Give to UH Search Close the search box Patients & Visitors Medical Professionals Research Community Medical Learners Volunteers Donors Employees Job Seekers Quick Links Make an Appointment Services UH MyChart Price Estimate Price Transparency Pay a Bill Medical Records Patient Experience Locations About UH Give to UH Careers at UH Close Menu Loading Results Find Doctors Services Locations Give to UH Search Close the search box Menu Because of You Campaign Support Opportunities Ways to Give Giving … ition with name/logo on tee signage at two (2) holes on course; deadlines apply Day of Event Recognition : Recognition on event signage and verbal acknowledgement during the event Name/logo Recognition : Logo and recognition as a Eagle Sponsor on UH Giving website with backlink to sponsor's website *Reservations made on a first-come, first-serve basis Birdie Sponsor - $5,000 ($4,300 Tax Deductible) Golf for four (4) individuals (1 foursome), includes food and beverages … nition with name/logo on tee signage at one (1) hole on course; deadlines apply Day of Event Signage: Recognition on event signage Name/logo Recognition : Logo and recognition as a Birdie Sponsor on UH Giving website with backlink to sponsor's website Par Sponsor - $3,000 ($2,300 Tax-Deductible) Golf for four (4) individuals (1 foursome), includes food and beverages throughout the course. Tee Signage Recognition: Recognition with name/logo on tee signage at one (1) hole … nition with name/logo on tee signage at one (1) hole on course; deadlines apply Day of Event Signage: Recognition on event signage Name/logo Recognition : Logo and recognition as a Par Sponsor on UH Giving website Foursome - $1,500 ($800 Tax-Deductible) Golf for four (4) individuals (1 foursome), includes food and beverages throughout the course. Hole Sponsor - $500 (100% tax-Deductible) Tee Signage Recognition: Recognition with name/logo on tee signage at one (1) … nition with name/logo on tee signage at one (1) hole on course; deadlines apply Day of Event Signage: Recognition on event signage Name/logo Recognition : Logo and recognition as a Hole Sponsor on UH Giving website Excludes golf Cocktail Reception and Dinner - $125 ($25 Tax-Deductible) Reservation for one to attend the cocktail reception an
%PDF-1.6 %���� 18 0 obj > endobj xref 18 39 0000000016 00000 n 0000001365 00000 n 0000001500 00000 n 0000001580 00000 n 0000001773 00000 n 0000001818 00000 n 0000001968 00000 n 0000002119 00000 n 0000002270 00000 n 0000002420 00000 n 0000002626 00000 n 0000002660 00000 n 0000002736 00000 n 0000003921 00000 n 0000005014 00000 n 0000006073 00000 n 0000006785 00000 n 0000007211 00000 n 0000007490 00000 n 0000007755 00000 n 0000008922 00000 n 0000009076 00000 n 0000009298 00000 n 0000010637 00000 n 0000012040 00000 n 0000013459 00000 n 0000014803 00000 n 0000017472 00000 n 0000037917 00000 n 00000
Biovision Ventures focus team portfolio news singular focus on life sciences and healthcare We support innovative early-stage companies with a mission to translate groundbreaking science into transformative therapies investment criteria Therapeutics We are agnostic about diseases and modalities, but prioritise companies developing novel platform-based therapeutic approaches with good IP protection or hard-to-replicate know-how addressing unmet clinical needs by generating proprietary assets Bio-IT We focus on medical software solutions for clinical use, as well as computational solutions for d … formation of its early-stage biotech portfolio and the USD 100M captive venture fund, where he served as an investment director and board member of the fund’s portfolio companies across the globe. In 2014, Alexey started his first venture fund, currently fully invested with a few successful exits. Alexey is responsible for business development, deal origination, and investor relations, while remaining deeply involved in the evaluation of investment opportunities and serving o … formation of its early-stage biotech portfolio and the USD 100M captive venture fund, where he served as an investment director and board member of the fund’s portfolio companies across the globe. In 2014, Alexey started his first venture fund, currently fully invested with a few successful exits. Alexey is responsible for business development, deal origination, and investor relations, while remaining deeply involved in the evaluation of investment opportunities and serving o … alyzing innovations behind target companies` technologies and helping build the fund`s pipeline. He is also active in expanding the KOL network and tracking trends in biosciences and pharmacology. Prior to Biovision Ventures, Ivan worked as a postdoc on telomere biology at the Institute of Molecular Genetics and on artificial signalling pathways at the University of Queensland. Before that, he worked as a visiting graduate student at California Institute of Technology, where … alyzing innovations behind target companies` technologies and helping build the fund`s pipeline. He is also active in expanding the KOL network and tracking trends in biosciences and pharmacology. Prior to Biovision Ventures, Ivan worked as a postdoc on telomere biology at the Institute of Molecular Genetics and on artificial signalling pathways
3 Qualities You Need To Attract Corporate Venture Capital Sign Up For Newsletters Games Share a News Tip Featured Featured Breaking News White House Watch Daily Cover Stories 2026 Forbes World's Most Influential CMOs List Making It Their Way: Six TikTok Creators On Finding A High-Quality Content Strategy That Pays Off | Paid Program The Hidden Tax On Enterprise AI: 1 In 5 Workers Lose A Full Day Every Week | Paid Program Silicon & Steel Editorial Video Series Turning Pressure Into Progress For Your Small Business | Paid Program Uniting To Advance Blood Cancer Research | Paid Program T … Managing Director at Intel Capital and co-leader of its $125 million Diversity Fund, a t a recent SF brunchwork at Alloy Collective , an award-winning collaborative workspace, arts & innovation hub. Intel Capital Managing Director Christine Herron discusses what she looks for in investments with brunchwork's Simran Arora. Karis Oasan Intel Capital is one of the most active CVCs in the world with over $566 million invested in 2017. Herron, who was previously an inves … nt backgrounds, experiences and skillsets. Intel launched a dedicated Diversity Fund in 2015 with a $125M commitment. “You have to find diverse teams. They exist. Go find them,” Herron said. Each investor at Intel Capital looks for diversity no matter their vertical. The fund’s definition of diversity has expanded over the years. Herron explained, “We want to pay attention to not only women and underrepresented minorities. We are actively looking for people with disabilities,
Tune into our Touchdown Ventures webinar with McKinsey & Company on corporate venture capital. https://lnkd.in/g6eK-SCG | Rich Grant LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Co … n content LinkedIn Top Content People Learning Jobs Games Join now Sign in Rich Grant’s Post Rich Grant 2y Edited Report this post Tune into our Touchdown Ventures webinar with McKinsey & Company on corporate venture capital. https://lnkd.in/g6eK-SCG David Horowitz 2y My colleague Kindra Tatarsky and I are excited to collaborate with McKinsey & Company on an upcoming webcast on corporate venture capital on June 13th. Matt Banholzer Sid R. Touchdown Ventures https://ln
Selective hearing: A survival skill in the corporate venture capital world - Global Venturing Global Venturing | Selective hearing: A survival skill in the corporate venture capital world Where Global Innovation and Capital Meet Home --> Register Login Go Corporate University Impact Full Site Corporate University Impact Daily Deal Round Up: May 25, 2021 Affirm spinoff Resolve raised $60m from investors including its parent company... Find Out More Daily Deal Round Up: May 25, 2021 Affirm spinoff Resolve raised $60m from investors including its parent company... Find Out More Daily Deal Round U … Jun 3, 2026 • Bill Taranto, founder and president, MSD Global Health Innovation Fund Nathan Grawe, an economist at Carleton College in Minnesota, a few years ago predicted US college-going students would drop by 15% between 2025 and 2029 and continue to decline by another percentage point or two thereafter given the marked drop in births after the global financial crisis struck in 2008. --> Seasoned corporate investors know they can't absorb every founder claim and C-suite op … t landscape. Find out more Ignore valuations that would make a sovereign wealth fund pause When CVC investors are new to the game, newcomers panic when a pre-revenue startup proposes a nine-figure valuation. “Is that… allowed?” they ask. Experience brings calm. These numbers aren’t real; they’re aspirational. You read them the way you read science fiction—with interest, skepticism, and emotional distance. When the founder eventually asks about valuation, you respond with the … of this sort is a reliable warning sign. Veterans know: Friday is an artificial deadline “Other investors” are often imaginary The data room will contain three files, one of which is a headshot You reply calmly: “We’ll take a closer look next week.” The deadline almost always disappears. From the corporation: Ignore the phrase: “We just need a small pilot to prove value” In corporate venture, “small pilot” usually translates into: Months of emails Secu … sting on CVC Compass. Bill Taranto is president of MSD Global Health Innovation Fund and vice president of MSD Global Health Innovation Group. MSD GHIF has $600M under management and provides growth capital to companies that improve healthcare delivery and services. For more than a decade, GHIF has invested in artificial intelligence and now back
Tune Therapeutics Stock Price, Funding, Valuation, Revenue & Financial Statements Technology Vendors Recent Research Newsletter Media Support Login Who We Serve Function Corporate Strategy Corporate Venture Capital Venture Capital IT Corporate Innovation How VCs Use CB Insights Go to the video gallery → Industries Consumer & Retail Tech Insurance Healthcare Industrials Financial Services Professional Services Professional Services Learn More → Success Stories How We Help Understand Tech Markets Anticipate Competitor Strategy Determine Tech Strategy Connect with Tech Vendors & Partn
All Tune Therapeutics articles | Drug Target Review Your browser is not supported Sorry but it looks as if your browser is out of date. To get the best experience using our site we recommend that you upgrade or switch browsers. Find a solution Skip to main content Skip to navigation Site name Site name Mast navigation Become a member Sign In Search our site Search our site Search Menu Close menu Home News Oncology AI Topics Back to parent navigation item Topics Technology Resources Diseases Drugs and therapies Research and development Tools and techniques Business Webinars Whitepapers Reports
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
TUNE SUPPLY - YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Ali Behbahani - Tune Therapeutics Skip to content The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Main menu The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Scientific Presentations Ali Behbahani Investor Dr. Ali Behbahani is a Board Member at Tune Therapeutics, and a General Partner at New Enterprise Associates (NEA). He specializes in investments in the biopharmaceutical and medical device sectors.
The Tune Supply Shop Skip to content Email [email protected] Home Duramax Duramax L5P (2024-2026) L5P (2024-2026) 2024-2025 L5P Tuning Bundles 2024-2025 L5P Hard Parts L5P (2020-2023) L5P (2020-2023) 2020-2023 L5P Tuning Bundles 2020-2023 L5P Hard Parts 2020-2023 L5P Turbos L5P Platform All 2020-2023 L5P Products L5P (2017-2019) L5P (2017-2019) 2017-2019 L5P Tuning Bundles 2017-2019 L5P Hard Parts 2017-2019 L5P Turbos L5P Platform All 2017-2019 L5P Products LML (2011-2016) LML (2011-2016) LML Tuning Bundles LML Hard Parts LML Turbos LML Platform All LML Products LMM (2007.5-2010) LMM (20
TUNE SUPPLY 0 Skip to Content Virtual Workshops Virtual Session Performance Production About/Contribute YouTube Channel Open Menu Close Menu Virtual Workshops Virtual Session Performance Production About/Contribute YouTube Channel Open Menu Close Menu Virtual Workshops Virtual Session Performance Production About/Contribute YouTube Channel We bring tunes to you. Traditional music performance, instruction, and community delivered digitally…and in the real world. Listen and watch on YouTube Virtual Workshops Tune Supply’s Ninth Batch of Virtual Learning Workshops: Summer 2026 Join us for our nin … onnected during these strange times, you can do so here. Thank you! TUNE SUPPLY Fund TUNE SUPPLY Photos by Jimmy O’Kelly, Anna Colliton , and Todd Paris . All rights reserved. Drop us a line: [email protected]
Join The Band - Tune Therapeutics Skip to content The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Main menu The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Scientific Presentations Join The Band Drawing upon deep, local talent pools in Durham and Seattle, Tune has assembled highly seasoned discovery and development teams with the potential to transform what is possible in the treatment of disease. Are you … sts Portrait Photography, Co-chair of the Ellia Yee High Risk Leukemia Research Fund @ Seattle Children’s, Keeping up with my two kids. Christina Jordan Senior Director, Intellectual Property Seattle Christina Jordan Senior Director, Intellectual Property Preferred Musical Genres Yacht Rock, Opera, Indie Rock Hobbies/Interests Swimming, learning how to operate a motor boat, and exploring new places. Jason Dean Senior Director, Bioinformatics Seattle Jason Dean Senior Director
TUNE Partners | TUNE Navigation Solutions Business Type Advertisers Networks Top Verticals Direct-to-Consumer Financial Services Subscription Services Why Tune TUNE Platform TUNE Partners Customers Professional Services Pricing For Advertisers For Networks Learn Resources Events Support Help Site Developer Site Training Contact Support About About TUNE Leadership Careers Contact Us Blog Solutions Business Type Advertisers Networks Top Verticals Direct-to-Consumer Financial Services Subscription Services Why Tune TUNE Platform TUNE Partners Customers Professional Services Pricing For Advertiser … ners know their clients receive the best technology in the industry, along with award-winning technical support. TUNE agency partners never have to worry about us encroaching on their business. Agencies provide a wide array of services for brands. In general, agencies help execute three key phases of a brand’s partner program: developing program strategy, managing the program, and optimizing program performance. GO TO AGENCY PARTNERS > PARTNER ECOSYSTEM Technology Partners TU
Novotech Wins Citeline CRO Partnership of the Year Award for Strategic Collaboration with Tune Therapeutics | Novotech CRO Sorry, you need to enable JavaScript to visit this website. Skip to main content Insights Solutions Expertise Company Talk To An Expert EN English KR 한국어 CN 简体中文 CT 繁体中文 Featured Thought Leadership Articles Featured media on Novotech’s leadership and impact. Blog Expert insights and real-world perspectives. White Papers In-depth perspectives on forces shaping clinical research. Disease Reports Tracking science and trends across therapeutic areas. Webina … adership. Careers Working at Novotech A global clinical research leader with an award-winning culture. Life at Novotech A culture that empowers growth, innovation, and impact. Current Opportunities Explore career opportunities at Novotech. Benefits and Recognition Benefits and recognition that support your success. Meet Our Teams Experts collaborating to advance clinical research. Career Growth and Development A commitment to your growth and development. Clinical Graduate Pro … adership. Careers Working at Novotech A global clinical research leader with an award-winning culture. Life at Novotech A culture that empowers growth, innovation, and impact. Current Opportunities Explore career opportunities at Novotech. Benefits and Recognition Benefits and recognition that support your success. Meet Our Teams Experts collaborating to advance clinical research. Career Growth and Development A commitment to your growth and development. Clinical Graduate Pro … ech May 14, 2025 Home / News Novotech Wins Citeline CRO Partnership of the Year Award for Strategic Collaboration with Tune Therapeutics Sydney, Australia – May 13, 2025 — Novotech a globally recognized full-service clinical research organization (CRO) and scientific advisory company, is proud to announce it has been awarded the Citeline CRO Partnership of the Year Award in recognition of its collaboration with Tune Therapeutics, a pioneering epigenetic editing company. This … benchmark for CRO–biotech partnerships. The CRO Partnership of the Year award honors outstanding collaboration between a CRO and a pharmaceutical or biotech company that has advanced clinical programs through strong alignment and shared goals. Sarah Anderson, Director of Therapeutic Strategy, and Steve Roan, Associate Director of B
Branch buys TUNE’s attribution platform Is your marketing visibility disappearing? See why competitors are outranking you and take back your market position with actionable insights. Identify traffic-stealing competitors Find untapped opportunities Create outperforming content Input Instant analysis. No card needed. mt logo Topics Account-based marketing (ABM) Agile marketing B2B marketing B2C marketing Content marketing Email marketing Event marketing Local / location marketing Marketing analytics Platforms HubSpot Salesforce Marketo Google Analytics 4 Resources Webinars Intelligence reports
Welcome! | TuneLicensing FAQ REGISTER Log In Cover Song Licensing Mechanical Licenses for the sale and distribution of cover songs. Share your music and earn revenue while meeting the legal requirements of covering a song. Our experts will get you licensed and ready for your release! We Now Offer Proof Of License! LEARN MORE Why Do You Need a License? When you record a cover version of someone else’s song and want to distribute it (via digital download or physical product [cd, vinyl, etc.]) then you need a mechanical license. A cover song is any new recording of a previously released song by s
Tune Therapeutics | Biotech Careers Skip to main content Biotech Careers Contact Submit an Employer Contact Add an Employer Search Open main menu Contact Submit an Employer Contact Add an Employer Search Main navigation Careers Job Areas People Articles Videos Biotech Companies Biotech Jobs Business Areas Tune Therapeutics Website: Tune Therapeutics Business Area(s) Epigenetics Cell and Gene Therapy Therapeutics Description Developing ways to control gene expression through epigenetics. Career Page(s) Careers [email protected] ... Company Location(s) 701 W. Main St. Durham , NC 27701 United S
Columbus, Ohio Show: Building & Renovation Expo | L&L shows OUR EVENTS About US Contact Us ATTEND Show Overview Hours and Directions Exhibitor List Ticket Discount Invite A Friend Picture Gallery DISCOUNT TICKET EXHIBIT Exhibitor's Overview Request Exhibitor Info Testimonials Multi Media Campaign Move-In Info/Forms Picture Gallery REQUEST EXHIBITOR INFO Columbus Building & Renovation Expo January 8-10, 2027 — Ohio Expo Center - Kasich Hall (see full date/times and location details) Exhibitor List Click on col
Sponsor: Consumer Compliance Conference - Florida Bankers Association About Us Our Staff & Values 2024-27 Strategic Plan Governance & Bylaws Advocacy Government Relations Florida BankPac Current Issues > Fraud Prevention Campaign Trust & Wealth Membership Join the FBA Peer Groups Endorsed Partnership Associate Membership Member Directory Member Login Education & Events Calendar Events List > Advanced Deposit Account Administration Annual Meeting > Annual Meeting Hotel Information Golf Outing BankPac Silent Auction Annual Meeting Networking Reception BSA/AML Symposium Capitol Day + Cap … l Sponsorships Available: Room Key Sponsor (Vendor graphic on room key cards) - Submit form below for pricing Wi-Fi Sponsor (Attendees brought to vendor's website/link) - Submit form below for pricing Lanyard Sponsor (Vendor to provide lanyards) - Submit form below for pricing Notebooks/Notepads Sponsor (Vendor to provide notebooks/notepads) - Submit form below for pricing Benefits are listed under Partner Sponsor Table-Top Exhibitor Information: Member Fee - $1,750 &# … st Title * Upload Logo File * Max file size: 20MB Email * Company Description * Submit Florida Bankers Association 1001 Thomasville Road, Suite 201 | Tallahassee, FL 32303 Phone: (850) 224-2265 | [email protected] Privacy Policy | Terms of Use | Image Glossary Copyright Florida Bankers Association. All Rights Reserved.  Staff Contact | ​Member Directory | Member Login | Disaster Recovery
Exhibitor Badge Registration | AWFS Fair Attend Why Attend? Show Features Register to Attend Hotel & Travel News Find Exhibitors and Sessions Exhibit Become an Exhibitor Exhibitor Prospectus International Exhibitors Exhibitor Sponsorship Book Participate in Show Features Badge Registration Education CWWK™ CWWK 2025 Highlights AWFS®Fair Live Freshwood Student Competition News AWFS® Cares Show Logos Stay in Tune Press Releases Hotels and More Hotel & Travel Show Schedule & Map AWFS®Fair FAQs Sponsors & Media Partners AWFS® Sustainable Contact Us Register EXHIBITOR BADGE REGIS
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
What We Do - The Exhibitor Advocate --> Skip to content About Show submenu for About Who We Are What We Do FAQ Resources Show submenu for Resources Resources & Tools Blog Ask an Advocate Membership Show submenu for Membership Why Join Directory Committees Connect Show submenu for Connect Events Sponsorship Opportunities Contact Us Log In About Show submenu for About Who We Are What We Do FAQ Resources Show submenu for Resources Resources & Tools Blog Ask an Advocate Membership Show submenu for Membership Why Join Directory Committees Connect Show submenu for Connect Events Sponsorship … ubscribe About Us Frequently Asked Questions Get Help Resources Recommendations Apply for Help Join Us Ways to Give Sponsorship Donate Contact Us Blog Events Recent Posts Why Trade Show Booths are Often Better Prepared than the People Working Them June 10, 2026 Read More » Understanding the EAC Fee June 10, 2026 Read More » Follow us on LinkedIn
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Last fall, Fine Tune Expense Management CEO Richard Ham shared a thesis with me: as corporate procurement has professionalized and grown, we've built an incentive structure that hinders rather than… | Philip Ideson LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices … lls 30+ years of global experience into practical wisdom every professional can apply. Whether you’re in audit, risk, compliance, procurement, or on a board, this episode will challenge how you think about assurance, resilience, and governance. 🎧 Tune in here: https://lnkd.in/g_4UbgNE A huge shout-out to Shagan for sharing not just technical expertise, but also the human side of risk culture, listening, humility, and storytelling as tools for stronger organizations. #RiskMan … lls 30+ years of global experience into practical wisdom every professional can apply. Whether you’re in audit, risk, compliance, procurement, or on a board, this episode will challenge how you think about assurance, resilience, and governance. 🎧 Tune in here: https://lnkd.in/g_4UbgNE A huge shout-out to Shagan for sharing not just technical expertise, but also the human side of risk culture, listening, humility, and storytelling as tools for stronger organizations. #RiskMan
SongDivision Changes its Tune adding wdth to play with stretch --> --> --> --> Magazine Articles by Topic Read the Magazine Magazine Subscriptions Renew, Update Address, Back Issues Portable/Modular Awards Enter Your Exhibit Corporate Event Awards Nominate Your Event All Awards Programs Free Newsletters Media Kit Education Certification Power Week EXHIBITOR LIVE 2027 Denver Save Your Seat! Trade Show Foundations A Full Day of the Basics eTrak Online Education Certification Certified Trade Show Marketer An overview of … ucers Rental Modular Exhibits Convention Centers All Companies News Latest News Submit Your News Free Newsletters Sign In Sign In Sign Out What's Happening Now EXHIBITOR LIVE 2027 - Denver, Colorado Save Your Seat and Save $645! eTrak University-Affiliated Online Learning Registration is Open! Submit your Session Proposal for EXHIBITOR LIVE 2027 --> Breaking News: IAEE Completes Acquisition of Exhibitor Group --> Corporate Event Awards Entry is Open Nominate Your Event! Trade … ransit 350 van parked in front of the convention center was ready to get things rolling. The rented vehicle was branded with custom vinyl-cling graphics on all four sides and manned by a driver, a professional videographer, and Sam McNeill, the company's creative director, who acted as the emcee. Roughly four times a day during the three-day show, bands of meeting and event execs, including leadership from the Senior Planners Industry Network, Maritz Global Events Inc., and M … they saw and heard that the company received a 27-percent bump in requests for proposal as a result of its IMEX exhibit. What's more, revenue from those RFPs led to SongDivision recouping its $20,000 IMEX investment more than seven times over. And as a final bonus, footage from the "Back Seat Karaoke" sessions was used in a marketing campaign for Global Meetings Industry Day the following year, extending SongDivision's investment even further. By capitalizing on the crowd-dr
Dull Men's Club® | Hello dullsters! I need help naming a tune
Exhibitor Activities You Don’t Want to Miss | NW Tune-up Festival | Bikes Beer Music Skip to main content NW Tune-up Festival | Bikes Beer Music Festival in Bellingham, WA in June 2020 Main navigation Home Bikes Music Culture TRAVEL Info Tickets RACING THOUGHTS? | Register now for our signature bike events! Exhibitor Activities You Don’t Want to Miss The music’s playing, the bikes are rolling and the waterfront’s buzzing—but the fun doesn’t stop with our main festival schedule. Our incredible vendors and exhibitors are bringing their own lineup of rides, contests, clinics and giveaways all wee … Research Freewheel Kit. Every participant gets at least one entry. CLAW MACHINE PRIZE GRAB Daily, 11 AM–2 PM Try your luck at the OR claw machine, packed with limited-edition prizes and exclusive giveaways. DISCOUNTED GEAR SALES Score Outdoor Research gear at festival-only prices. Shimano XTR ATHLETE GROUP RIDES Sign up prior to ride at the Shimano Booth. Spots are limited. Friday • 9:30 AM — Led by Talus Turk, Bryn Atkinson & Jill Kintner • 3 PM — Led by Thomas Vanderham … trol, and style. Meet at the Giant booth and let's get airborne. Peak Hydration PRIZE WHEEL & GIVEAWAYS All Weekend Spin to win free B12 shots, discounted services, merch, and more. ON-SITE IV THERAPY & WELLNESS SHOTS Rehydrate and recharge with Peak Hydration’s on-the-spot wellness services. Santa Cruz Bicycles OWNERS CLUB RIDE WITH ELIOT JACKSON & HAILEY ELISE Friday, 10 AM Meet at the Santa Cruz booth and ride with fellow Santa Cruz owners. HAPPY HOUR & FRE
Reed Jobs - Tune Therapeutics Skip to content The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Main menu The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Scientific Presentations Reed Jobs Investor Reed Jobs is an Investor at Yosemite and manages Yosemite. Yosemite works exclusively in the oncology space, using flexible capital to advance science with the goal of making cancer non-lethal in our lifetime. Ov
Guitar Tuner - Simply Tune - Apps on Google Play Games Apps Books Kids google_logo Play Games Apps Books Kids none search help_outline Sign in with Google play_apps Library & devices payment Payments & subscriptions reviews My Play activity redeem Offers Play Pass Personalization in Play settings Settings Privacy Policy • Terms of Service Games Apps Books Kids Guitar Tuner - Simply Tune Simply Ltd 4.7 star 35.9K reviews info USK: All ages info 500K+ Downloads Install Share Add to wishlist USK: All ages Learn more About this app arrow_forward World's #1 Best-Reviewed Guitar Tuner Ap … UNITY: From the creators of Simply Guitar, Simply Tune is part of JoyTunes' award-winning suite of music apps. Join tens of thousands of music teachers and millions of learners who trust JoyTunes for their musical journey. WE VALUE YOUR FEEDBACK: Your experience with Simply Tune matters to us. Share your feedback and suggestions at [email protected] to help us improve your tuning experience. ABOUT JOYTUNES: JoyTunes are experts in creating educational and engaging musi
Dyno Vs Road Tuning Vs E-Tune × Sale ends today Get 30% off any course (excluding packages) Ends in --- --- --- English Español Member Login Courses EFI Tuning Motorsport Wiring Engine Building Diesel Tuning Automotive CAD Automotive Fabrication Suspension and Car Setup Driver Training and Improvement Electric Vehicles VIP Package Most Popular Starter Packages Best Value VIP Package Instant access to EVERY course (including all future courses), free t-shirts and more. Tuning Package Wiring Package Automotive CAD Package Engine Building Package Diesel Tuning Package Fabrication Package Track Da … Let’s start by talking about what a dyno is. In a nutshell, the dyno is used to apply a load to the engine to replicate driving the car on the road. As well as being able to apply a load to the engine, the dyno will also be able to measure the torque being produced and from this, the engine power can be calculated. Depending on how smart or advanced the dyno is, it will also be able to log parameters such as boost pressure and air fuel ratio and provide the tuner with torque … the mass of the roller and the rate of acceleration. These inertia dynos can’t apply a variable load to the engine and hence it’s difficult or impossible to operate the engine at a fixed rpm. Inertia dynos, however, are cheaper to manufacture and can do an adequate job if you only want to test the engine at full throttle. A load bearing dyno, on the other hand, will have some form of power absorber module (hydraulic, eddy current or water brake are all popular techniques) th … ning? We've helped 205,342 people just like you learn the science of tuning and apply it to their own projects. Interested in learning more? Check out these courses Share Facebook 𝕏 Email LinkedIn WhatsApp You Might Be Interested In... You Might Be Interested In... About the author Andre Simon Andre Simon is the technical co-founder of High Performance Academy (HPA), a leading performance industry-based education provider. With over 20 years of experience in the industry, An … log and News Contact Us High Performance Academy Limited © 2026 Name Email Submit Close $50 OFF Just for you. Your friend has given you $50 off your first course! No coupon needed. Email Use Discount Close Want $50 OFF Your Next Course? Send this link to your mates to get $50 OFF their first course. If they enroll we will email you a discoun
Guitar Tuner - Simply Tune App - App Store for iPhone iPhone iPad Mac Vision Watch TV Search Today Games Apps Arcade Platform iPhone iPad Mac Vision Watch TV Guitar Tuner - Simply Tune Ads Free, Everything Unlocked Only for iPhone Free Share 98K Ratings 4.8 Age Rating 4+ Years Chart #78 Music Developer Simply Ltd Language EN + 10 More Size 168.2 MB iPhone World's #1 best-reviewed guitar tuner app! 100% free premium tuner with chords & songs With lots of different instruments to choose from, you can be tuning your guitar, bass or ukulele with fun and ease, so that it plays at perfect pitch … simply.com --- Good to know --- Simply Tune is created by Simply, developers of award-winning apps Simply Piano and Simply Guitar. Simply are experts in creating educational and fun music apps for learning to play quickly and easily. Recommended and used by tens of thousands of music teachers worldwide with over 1 million songs learned every week. Awards & Recognition: “Editors' Choice” by Apple SF Music Tech Summit Startup Innovators Challenge Winner Best Tool for Beginn … ovators Challenge Winner Best Tool for Beginners, NAMM EMI Innovation Challenge Award --- Contact --- Have questions, feedback or suggestions? Reach out to us at [email protected] Privacy policy: https://www.hellosimply.com/legal/privacy Terms of use: https://www.hellosimply.com/legal/terms more Ratings & Reviews 4.8 out of 5 98K Ratings Better than others 02/03/2023 Oskar473 I was a fan of Guitar Toolkit, before it was abandoned by the developer and stopped functionin
Tune Therapeutics | MTEC MTEC Focus Areas Who we serve Solicitations Patents About Us Explore Join MTEC Log In Life Sciences / Companies Tune Therapeutics Tune Therapeutics is pioneering a new therapeutic modality that can fine-tune any gene network. The company is developing solutions for challenging diseases and building capacity to transform human health and medicine. Their proprietary platform, TEMPO, enables precise control over gene activity without altering DNA, expanding the scope of genetic medicine to address common, chronic, and age-related diseases. Their mission is to bring gene,
Fyodor Urnov - Wikipedia Jump to content Main menu Main menu move to sidebar hide Navigation Main page Contents Current events Random article About Wikipedia Contact us Contribute Help Learn to edit Community portal Recent changes Upload file Special pages Search Search Appearance Donate Create account Log in Personal tools Donate Create account Log in Contents move to sidebar hide (Top) 1 Early life and education 2 Career 3 Honors and awards 4 References 5 External links Toggle the table of contents Fyodor Urnov Add languages Add links Article Talk English Read Edit View history Tools Tools m … [ 16 ] [ 17 ] Tune raised a $40M Series A and $175M Series B to fund its efforts in therapeutic development. [ 18 ] [ 19 ] Honors and awards [ edit ] 2024 Horace Mann Medal, Brown University [ 20 ] References [ edit ] ^ Urnov, Fyodor Dmitriyevich (1996). The origin of DNA amplification in Sciara coprophila DNA puff II/9A: nucleotide sequence, chromatin structure, and protein-DNA interactions (Thesis). OCLC   83539763 . ^ Урнов, Дми … the Creative Commons Attribution-ShareAlike 4.0 License ; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy . Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc. , a non-profit organization. Privacy policy About Wikipedia Disclaimers Contact Wikipedia Legal & safety contacts Code of Conduct Developers Statistics Cookie statement Mobile view Search Search Toggle the table of contents Fyodor Urnov Add langua
$ COI disclosure: I am a scientific co-founder of Tune and thus hold equity in it. Data have no coi - and they are objectively spectacular. I could not have _dreamt_ that epiediting - true… | Fyodor Urnov LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time i
Chroma Medicine and Tune Therapeutics: Two companies take up epigenome editing | Fyodor Urnov LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to Lin
Fyodor Urnov - Tune Therapeutics Skip to content The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Main menu The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Scientific Presentations Fyodor Urnov Co-Founder Dr. Fyodor Urnov is a Co-Founder and member of the Scientific Advisory Board at Tune Therapeutics. A pioneering presence in the field, Fyodor is Professor of Genetics, Genomics, and Development at UC Berk … 3). He was also a key member of the team that developed the first in-human application of genome editing in 2009, and co-led teams developing the first in vivo epigenome editors for Huntington’s Disease and Tau dementia (2010-2016). He received his Ph.D. in Biology from Brown University, and was a postdoctoral fellow at the National Institutes of Health in the laboratory of Dr. Alan P. Wolffe. Home The Science Epigenomics TEMPO Platform Applications About Us Join The Ban
Tune Therapeutics' 2025 Epigenome Editing Outlook Get more Cell & Gene insight with our FREE newsletter sign me up Log In or Subscribe Explore CGT Production Vectors Cell Therapy Manufacturing Gene Therapy Manufacturing Formulation Fill-Finish Cold Chain Management Quality Control & Assurance Find Suppliers Clinical Trial Services Manufacturing Regulatory Supply Chain Outsourcing Translational Research Watch Now STREAM Video Channel Cell & Gene Live Cell & Gene: The Podcast Cell & Gene Tech Expo Our Communities Advancing RNA Bioprocess Online Clinical Leader Clinical Supply
Derek Jantz - Tune Therapeutics Skip to content The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Main menu The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Scientific Presentations Derek Jantz Chief Scientific Officer Derek Jantz is the Chief Scientific Officer at Tune Therapeutics. A veteran entrepreneur with deep expertise in developing cell and gene therapeutics, Dr. Jantz was previously CSO at Precision
Dan McHugh - Director at Tune Therapeutics | The Org Platform Enrich Pricing Log in Sign up Tune Therapeutics Dan McHugh Unverified Dan McHugh Director Contact Dan McHugh is a Board Member at Tune Therapeutics and a Senior Director at Emerson Collective. Dan is a Senior Director at Emerson Collective where he has been leading the organization’s life sciences investment efforts since 2016. At Emerson, he supports companies developing novel therapeutics, diagnostics, and other enabling technologies with the potential for impact in oncology. Prior to Emerson Collective, Dan was a strategy consu
Dan McHugh - Tune Therapeutics Skip to content The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Main menu The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Scientific Presentations Dan McHugh Co-Founder, Investor Dan McHugh is a Co-Founder & Board Member at Tune Therapeutics, and Lead Investor at Yosemite In his role as Lead Investor at Yosemite, Dan supports companies developing novel therapeutics, diag
Charles Gersbach - Tune Therapeutics Skip to content The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Main menu The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Scientific Presentations Charles Gersbach Co-Founder Dr. Charles A. Gersbach is a Co-Founder of Tune Therapeutics. A renowned academic and genome engineer, Charlie is the John W. Strohbehn Distinguished Professor of Biomedical Engineering at Duke Un
Akira Matsuno - Tune Therapeutics Skip to content The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Main menu The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Scientific Presentations Akira Matsuno Co-Founder, President, CFO, COO Akira Matsuno is the President, Co-Founder, Chief Financial Officer, and Chief Operating Officer at Tune Therapeutics. An accomplished biotech executive with a background in cell &a
Companies - Icon Ventures Companies Team About Us Perspectives Careers ✕ Companies Team About Us Perspectives Careers Meet Our Portfolio Icon’s portfolio spans 22 years of partnering with founders to build market leaders—from enterprise software and infrastructure to digital health. We are now applying this same foundational approach to the next wave of AI innovators. Portfolio All Acquisition & IPOs Active Companies Sectors All Enterprise Data Management Cybersecurity Digital Health Consumer Acquired by Experian 41st Parameter provides highly accurate, non-intrusive Internet fraud solutio … ORE AREA 1 Acquired by Grafana Labs Asserts is using AI to efficiently identify application and infrastructure problems. Co-Investors: Andreessen Horowitz Founders: Manoj Acharya Market Segment: Enterprise Acquired by: Grafana Labs SEE MORE Asserts Acquired by Teradata Aster Data is a leader in big data management and analysis for data-driven applications. Co-Investors: Sequoia, IVP, First Round Capital Founders: Myank Bawa, Tasso Argyros, George Candea Market Segment: Data M … en’s and family health. Co-Investors: Sequoia, Oak HC/FT, Female Founders Fund, Harmony Partners Founders: Kate Ryder Market Segment: Digital Health SEE MORE Maven Medeloop is an AI-driven startup revolutionizing medical research, with a platform that automates the entire research cycle – from grant discovery to data analysis. Co-Investors: General Catalyst, Inovia Capital Founders: Rene Caissie, Raghav Samavedam, Josh Walonski Market Segment: Digital Health SEE M … PO) Palo Alto Networks provides next-generation firewalls that enable unmatched application visibility and policy control. Co-Investors: Sequoia, Greylock Founder: Nir Zuk Market Segment: Cybersecurity IPO: PANW SEE MORE Palo Alto Networks Paravision is the world’s most advanced face recognition platform. Co-Investors: Khosla Ventures, Felicis Ventures Founders: Andrew Dudum, Jack Abraham, Jonathan Mumm, Charlie Melbye, Don Holly Market Segment: Enterprise SEE MORE Paravision … lepoint SEE MORE Pertino MYPS (SPAC) PlayStudios is a developer and operator of award-winning free-to-play casual games for mobile and social platforms. Co-Investors: DCM Founders: Andrew Pascal, Paul Mathews, Katie Bolich, Nicholas Koenig, Chad Hansing, Monty Kerr Market Segment: Consumer SPAC: MYPS SEE MORE Playstudios Acquired by Twitter Poste
News: Tune Therapeutics to Initiate Clinical Trial of First-In-Class Epigenetic Silencer in Chronic Hepatitis B - CRISPR Medicine Logo mobilemenu close CMN Live Home Clinical Trials CMN DB 2.0 CRISPRMED CRISPRMED24 CRISPRMED25 CRISPRMED26 WDC CRISPRMED26 Contest CRISPRMED26 Conference Kit CRISPRMED27 CRISPRMED Website Policies EGMEDC CMN Intelligence Webinars CMN Webinars On-demand - All CMN Webinar - Disrupting the Care of Cardiovascular Disease With Single-Course Gene Editing Medicines CMN Webinar - Taking the Guesswork Out of Drug Development: CRISPR-Select Validates Drug Targets and Drug R … c Silencer in Chronic Hepatitis B Tune Therapeutics has received clinical trial application approval from the New Zealand Medicines and Medical Devices Safety Authority to initiate a Phase 1b clinical trial for TUNE-401, an investigational epigenetic silencing therapy designed to treat chronic Hepatitis B. By: Karen O'Hanlon Cohrt - Nov. 21, 2024 Email Facebook Linkedin Twitter Seattle-headquartered Tune Therapeutics announced in a recent press release that New Zealand's … and Medical Devices Safety Authority (MEDSAFE) has approved its clinical trial application for TUNE-401. This approval means that Tune can begin a Phase 1b clinical trial of its epigenetic silencer TUNE-401 in adults with chronic hepatitis B (HBV). According to recent World Health Organization statistics , HBV resulted in an estimated 1.1 million deaths in 2022, and an estimated 254 million people are living with chronic HBV globally. The virus is transmitted through blood a … rapeutics has received U.S. FDA clearance of its Investigational New Drug (IND) application for BEAM-304, an in vivo base-editing therapy for... CARBON Newsletter (19 June 2026) - Your Latest... Carbon Jun. 19, 2026 Some of the best links we picked up around the internet Scaling CRISPR-based gene editing through advanced... Sponsored content Jun. 18, 2026 Addressing manufacturing bottlenecks in the transition to clinical scale. Clinical: Single CRISPR Infusion Curbs Hereditar
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Careers - Tune Therapeutics Skip to content The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Main menu The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Scientific Presentations Careers If you are seeking to verify the authenticity of a job posting, Tune Careers contains the official list of all open positions. If a position is not listed here, then we are not currently hiring for it. We conduct job intervie
NRF 2027: Retail's Big Show | NRF 2027: Retail's Big Show NRF .com NRF Foundation NRF Events NRF Sponsorship About NRF Membership Login Attend Schedule Expo Exhibit/Sponsor Get updates ABOUT NRF 2027 Event Overview Who Attends Attendee Demographics Call for Speakers 2026 Event Recap Get Updates REGISTRATION INFO Pass Types Retail Teams Retail Expo Pass NRF Global Network CONFERENCE INFO Agenda Session Topics Networking Programs ADDITIONAL PROGRAMS Media in Retail Summit Retail's Big Concert Retail Store Tours Expo Tours FOR ATTENDEES Expo Overview 2027 Exhibitors Expo Map Exhibi
Tune Therapeutics Strengthens Leadership Team with Addition of Dr. Derek Jantz as Chief Scientific Officer and Zachary Hale as General Counsel — Duke OTC Skip to main content Faculty & Innovators Industry & Partners New Ventures Digital Innovations Duke Capital Partners Students Translational Funds About About Us A Century of Innovation Team By The Numbers Invented at Duke Contact News Events Pipeline Technologies Resources Submit an Invention Innovate Login Search Search Site About About Us A Century of Innovation Team By The Numbers Invented at Duke Contact News Events Pipeli … he Numbers Invented at Duke Contact News Events Pipeline Technologies Resources Submit an Invention Innovate Login Search Search Site Faculty & Innovators Industry & Partners New Ventures Digital Innovations Duke Capital Partners Students Translational Funds News Home › News › Tune Therapeutics Strengthens Leadership Team with Addition of Dr. Derek Jantz as Chief Scientific Officer and Zachary Hale as General Counsel Clinical Trials Digital Innovation Engineering En … ail Address * Job Title * Affiliation * I'm interested in: (Click all that apply) New Technologies Resources News, Events, Funding Opportunities Topics of Interest Life Sciences Engineering/Physical Sciences Medical Devices Digital Innovations Subscriber consent I consent to having my subscriber engagement tracked and analyzed. By clicking submit I consent to receive email as stated by these terms. Submitting
SEC Network presents complete coverage of the College Football Playoff Semifinals - ESPN Press Room U.S. Search for Contact Instagram Vimeo YouTube LinkedIn Twitter Facebook Menu ESPN Press Room U.S. ESPN Press Room Brasil ESPN Press Room Caribbean ESPN Press Room Latin America South ESPN Press Room Latin America North Press Releases Media Kits ESPN Media Conference Calls Bios Programming Live Events and Commentators by Sport Daily Programming Schedule | Search Schedule About ESPN Mission and Values ESPN, LLC Fact Sheet James Pitaro, Chairman, ESPN and Sports Content ESPN Front Row ESPN Images … ion with The Paul Finebaum Show and SEC Now , original content such as the Emmy Award-winning TrueSouth , SEC Storied and SEC Inside , and more. Hundreds of additional live events are available for streaming exclusively on SEC Network’s digital companion, SEC Network+, via the ESPN App and SECNetwork.com . Follow SEC Network on Instagram , TikTok , Facebook and Twitter/X . Katie Callahan January 6, 2026 Facebook Twitter LinkedIn Katie Callahan Related Media Kits SEC Network R
Concord Acquires Ninja Tune Records - Concord - News About Label Group Artists Record Labels New Releases Mediakits Music Publishing Roster Boosey & Hawkes Pulse Music Group Rodgers & Hammerstein Theatricals Originals News Licensing Careers Working at Concord Search Jobs Internships Contact Search & Filter Search: Search for: All Corporate News Label Group Music Publishing Originals Theatricals Search: Search for: Concord Acquires Ninja Tune Records March 12, 2026 NASHVILLE, TN – Concord, the world’s leading independent music company, announced today that it has acquired indie, UK-ba
Careers - Tune Therapeutics Skip to content The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Main menu The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Scientific Presentations Careers If you are seeking to verify the authenticity of a job posting, Tune Careers contains the official list of all open positions. If a position is not listed here, then we are not currently hiring for it. We conduct job intervie
And... we're live! Tune... - Epilepsy Foundation of Michigan Facebook Log In Epilepsy Foundation of Michigan's Post Epilepsy Foundation of Michigan April 11 · Shared with Public And... we're live! Tune in now to watch the Epilepsy Innovation Conference: https://youtu.be/RA_noHsGS_k Thank you to our sponsor: Corewell Health youtube.com 2026 Epilepsy Innovation Conference All reactions: 12 3 shares Like Comment
John McHutchison - Tune Therapeutics Skip to content The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Main menu The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Scientific Presentations John McHutchison CEO, Chairman of the Board John McHutchison AO, MD is Chief Executive Officer and Chairman of the Board at Tune Therapeutics. John is a noted biopharma industry leader with extensive experience in advancing … ry from the University of Melbourne in Australia, and completed a post-doctoral fellowship in Liver Diseases at the University of Southern California. He is a member of the Royal Australasian College of Physicians, and was appointed an Officer of the Order of Australia (AO) in 2018. Home The Science Epigenomics TEMPO Platform Applications About Us Join The Band Our Values Contact Us News & Insights Media Inquiries [email protected] Career Inquiries [email protected] Partnerin
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
I am excited to announce today the acquisition of TUNE by Constellation Software Inc. This is a big deal for many reasons, but one in particular is that we will now be playing on the same team as… | Peter Hamilton | 180 comments LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update yo
Tune Therapeutics Names John McHutchison as CEO and Chairman of the Board - Duke Capital Partners | Duke Capital Partners LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join
DataTune - Nashville 2026: Community Data and Tech Conference Workshops Sessions Speakers Event Info Contact --> Location Schedule Post Event Social Good to Know Questions About Sponsors Organizers Code of Conduct Workshops Sessions Speakers Event Info All Event Info Contact --> Location Schedule Post Event Social Good to Know Questions About Sponsors Organizers Code of Conduct --> DATATUNE 2026 NASHVILLE'S PREMIER DATA & AI CONFERENCE Thanks for joining us for DataTune 2026 Let's tune the future of data together. 2 DAYS → 4 TRACKS → 7 WORKSHOPS → 60+ SPEAKERS → WHAT IS DATATUNE? A community-d
Tune Therapeutics Names John McHutchison as CEO and Chairman of the Board - Tune Therapeutics Skip to content The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Main menu The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Scientific Presentations Tune Therapeutics Names John McHutchison as CEO and Chairman of the Board Renowned hepatologist and drug developer set to guide company’s next phase of growth &nb … enerative therapies into a new era of human medicine – expanding their range of application from rare disease to common, chronic, and age-related conditions. Media Contact Glenn Murphy, Director of Communications: [email protected] Home The Science Epigenomics TEMPO Platform Applications About Us Join The Band Our Values Contact Us News & Insights Media Inquiries [email protected] Career Inquiries [email protected] Partnering Inquiries [email protected] Durham 3
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
NAC transcription factors transcriptionally fine-tune signal homeostasis in plant systemic acquired resistance NAC transcription factors transcriptionally fine-tune signal homeostasis in plant systemic acquired resistance Physiol Plant . 2025 Jan-Feb;177(1):e70123. doi: 10.1111/ppl.70123. Authors Hui Wang 1 2 3 , Leeza Tariq 1 2 3 , Yuqing Yan 1 2 3 4 , Yan Bi 1 2 3 , Fengming Song 1 2 3 Affiliations 1 National Key Laboratory for Rice Biology and Breeding, Ins
Tune Therapeutics Strengthens Leadership Team with Addition of Dr. Derek Jantz as Chief Scientific Officer and Zachary Hale as General Counsel - Tune Therapeutics Skip to content The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Main menu The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Scientific Presentations Tune Therapeutics Strengthens Leadership Team with Addition of Dr. Derek Jantz as Chief Scientific
News: Tune Therapeutics' HBV Epigenetic Silencer: Clinical Trial Programme Expands to Hong Kong - CRISPR Medicine Logo mobilemenu close CMN Live Home Clinical Trials CMN DB 2.0 CRISPRMED CRISPRMED24 CRISPRMED25 CRISPRMED26 WDC CRISPRMED26 Contest CRISPRMED26 Conference Kit CRISPRMED27 CRISPRMED Website Policies EGMEDC CMN Intelligence Webinars CMN Webinars On-demand - All CMN Webinar - Disrupting the Care of Cardiovascular Disease With Single-Course Gene Editing Medicines CMN Webinar - Taking the Guesswork Out of Drug Development: CRISPR-Select Validates Drug Targets and Drug Responders Early … rapeutics has received U.S. FDA clearance of its Investigational New Drug (IND) application for BEAM-304, an in vivo base-editing therapy for... CARBON Newsletter (19 June 2026) - Your Latest... Carbon Jun. 19, 2026 Some of the best links we picked up around the internet Scaling CRISPR-based gene editing through advanced... Sponsored content Jun. 18, 2026 Addressing manufacturing bottlenecks in the transition to clinical scale. Clinical: Single CRISPR Infusion Curbs Hereditar
Tune Therapeutics Welcomes Noted Industry Leader Dr. John McHutchison to Board of Directors - Tune Therapeutics Skip to content The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Main menu The Band About Our Values Join The Band Careers The Science TEMPO Platform Applications Epigenomics Investors & Media News & Insights Scientific Presentations Tune Therapeutics Welcomes Noted Industry Leader Dr. John McHutchison to Board of Directors Former Assembly Bio and Gilead exec brings decades of exp
Facebook Explore the things you love . Log into Facebook Email or mobile number Password Log in Forgot password? Create new account English (US) فارسی العربية Türkçe Deutsch Français (France) Polski More languages… Sign Up Log In Messenger Facebook Lite Video Meta Pay Meta Store Meta Quest Ray-Ban Meta Meta AI Instagram Threads Privacy Policy Privacy Center About Create ad Create Page Developers Careers Cookies Ad choices Terms Help Contact Uploading & Non-Users Meta © 2026
Acquisition function for scoring parameter combinations — prob_improve • tune Skip to content tune 2.1.0 Get started Reference Articles Acquisition functions Optimizations and parallel processing Learn more Grid search Bayesian optimization of classification model Tuning text models Changelog Acquisition function for scoring parameter combinations Source: R/acquisition.R prob_improve.Rd These functions can be used to score candidate tuning parameter combinations as a function of their predicted mean and variation. Usage prob_improve ( trade_off = 0 , eps = .Machine $ double.eps ) exp_improve (
%PDF-1.7 %���� 724 0 obj > endobj 766 0 obj >/Filter/FlateDecode/ID[ ]/Index[724 53]/Info 723 0 R/Length 116/Prev 119347/Root 725 0 R/Size 777/Type/XRef/W[1 3 1]>>stream h�bbd```b``:"'�H��`�>��L��lE`v%�� fg�IA��� ��H2����d��ظDX�$�.�&N �������O d`bd`J���H�����@�LK� endstream endobj startxref 0 %%EOF 776 0 obj >stream h�b``�```Z����8�*`b�d1 (f`8� �&�x�E�Ŝe#��%,+XX���:2���� �� N�@E >/Metadata 9 0 R/Pages 722 0 R/StructTreeRoot 13 0 R/Type/Catalog/ViewerPreferences 767 0 R>> endobj 726 0 obj >/MediaBox[0 0 612 792]/Parent 722 0 R/Resources >/Font >/Pattern >/ProcSet[/PDF/ … �*9R��E�q��F��4l���u�yiۿW�y����BOʼl0_�� 0YT�� endstream endobj 9 0 obj >stream application/pdf FB5C711EF0E81C2F0D8ACF3AB84C411F Gulley, Mark Shannon 2025-06-16T20:46:42Z 2025-06-16T14:47:45-06:00 2025-06-16T14:47:45-06:00 uuid:36168949-4364-4868-AE5B-9CABC5E001CD uuid:1a1b3ae4-70d5-6644-b06f-ca1cde3f50c1 endstream endobj 10 0 obj >stream h�272R0P���w�/�+Q0���L)�672���T��$����� L endstream endobj 11 0 obj >stream h�\�A �0�ῲ��}���"�t���N�F�d�1�� :u~����4���b~ … ��+�+�+D�B�B����qW^~�� endstream endobj startxref 116 %%EOF 9 0 obj >stream application/pdf 2025 Startup Schedule Version 2.0 Kerstiens, Eron Lyle 2025-06-16T20:46:42Z 2025-06-16T14:49:13-06:00 2025-06-16T14:49:13-06:00 uuid:36168949-4364-4868-AE5B-9CABC5E001CD uuid:79c0d1a2-0425-8047-8f10-e4397443abca endstream endobj 777 0 obj > endobj 778 0 obj >/Filter/FlateDecode/ID[ ]/Index[9 1 777 2]/Info 777 0 R/Length 24/Prev 116/Root 725 0 R/Size 779/Type/XRef/W[1 3 0]>>stream h
Transnetyx Announces Acquisition of a-tune - a-tune software AG de en Back Homepage Products & Services Company News & Events Downloads Contact Request Demo Support Resource Library Legal Notice Privacy Statement tick@lab Animal Research Facility Software tick@lab Research Compliance Software Data Integration & Enterprise Applications Archive.Manager E-WorkBook.Deployment Data.Manager File.Manager Catalog.Inspector Chemistry.System.Integration Label.Printer In-vivo.Workbench Application.Insight Template.Reporter Study.Reporter Information.Portal tick@lab add-ons About us Careers … required service and unblock content You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers. More Information Unblock content Accept required service and unblock content You are currently viewing a placeholder content from Turnstile . To access the actual content, click the button below. Please note that doing so will share data with third-party providers. More Information Unblock content Accept require
Exclusive: Bucking gene editing downturn, Tune raises $175M to bring epigenetic editing to clinic | PackGene Biotech Discovery and Preclinical AAV Packaging Services AAV Production Services AAV Packaging – Research Grade AAV Packaging – NHP Grade Express Gene-to-AAV Service Off the Shelf AAV Products AAV Testing Services AAV Testing Services Mass Photometry AAV Genome Titer by ddPCR AAV Empty/Full Capsid Ratio Test by AUC AAV Genome Integrity by CE AAV Genome Sequencing by Nanopore AAV Capsid Services Capsid Engineering AAV Capsid Discovery Kits AAV Capsid & Gene Library Services Lentivir … t targets co-infections of hepatitis B and D as its lead therapy. It expects to apply to start human testing in 2025. On paper, Tune’s and nChroma’s editors seem nearly indistinguishable. Jantz said important details on how the two treatments may be different haven’t been disclosed. Tune’s hepatitis B program has been cleared for human testing by regulators in New Zealand and Hong Kong. “The most obvious difference is, we seem to be pretty far ahead,” Jantz said. “Honestly, w
S-1/A 1 primemedicines-1a2.htm S-1/A Document As filed with the Securities and Exchange Commission on October 17, 2022. Registration No. 333 – 267579 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Prime Medicine, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 2836 (Primary Standard Industrial Classification Code Number) 84-3097762 (I.R.S. Employer Identification No.) Prime Medicine, Inc. 21 Erie S … prospectus. Some data are also based on our good faith estimates. We intend to apply for various trademarks that we use in connection with the operation of our business. This prospectus may also contain trademarks, service marks and trade names of third parties, which are the property of their respective owners. Our use or display of third parties’ trademarks, service marks, trade names or products in this prospectus is not intended to, and does not imply a relationshi … al is to transform the lives of patients with debilitating diseases through the application of our ground-breaking Prime Editing platform and technology. Our key focus is on patients. We are committed to developing safe and efficient therapeutics using Prime Editing approaches to address high unmet need across a broad spectrum of diseases, from rare genetic diseases to severe, chronic and acute diseases, and ultimately to prevent disease before it occurs. Key components of ou … Editing in the service of patients. • Deploy our technology to extend the application of one time potentially curative therapeutics to areas that we believe were not addressable before. • Advance our pipeline while simultaneously enhancing, validating and enabling our Prime Editing platform. • Continue to push the frontier of innovation in gene editing by optimizing and expanding our Prime Editing technology and capabilities. • Opportunistically evalua … h new and innovative technological developments in Prime Editing and extend its application beyond rare genetic diseases and towards our goal of more broadly addressing human disease. These programs remain in the early stages of conception and will become an increasing focus over the next few years. 5 • “March up the chromosome”